Continence Care Market Size, Share and Growth Outlook, 2026

Continence Care Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Continence Care Market size is forecast to increase from $23.75 Billion in 2026 to $42.67 Billion in 2034 at a CAGR of 7.6% between 2026 and 2034.

The Continence Care market report provides detailed analysis and outlook of Continence Care segments including By Product Type (Absorbent Products, Non-Absorbent Products, Skin Care Products ), By Condition (Stress Incontinence, Urge Incontinence, Mixed Incontinence, Functional Incontinence, Fecal Incontinence), By Material (Plastic, Cotton Fabrics, Super Absorbent Polymers, Latex and Silicone ), By Gender (Male, Female), By End User (Hospitals and Clinics, Home Care Settings, Ambulatory Surgical Centers, Nursing Homes and Long-term Care Facilities) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Continence Care Industry Overview

Innovation in Incontinence Management Driving Product Development

The continence care industry is undergoing significant transformation as manufacturers and healthcare providers focus on improving patient comfort, clinical outcomes, and quality of life for individuals affected by urinary and fecal incontinence. Rising prevalence of diabetes, aging populations, neurological disorders, and lower urinary tract dysfunctions are increasing demand for advanced continence management products and diagnostic technologies. Industry participants are investing in specialized absorbent products, minimally invasive treatment solutions, and next-generation diagnostic systems designed to enhance patient care while reducing complications associated with long-term continence conditions.

Specialized Incontinence Products Addressing Disease-Specific Needs

Manufacturers are increasingly developing targeted continence care solutions for specific patient populations. Unicharm India Private Limited introduced a diabetes-focused adult diaper portfolio under its Lifree brand to address frequent urination and urinary incontinence commonly experienced by diabetic patients. The products incorporate features such as Heaviness Guard technology to maintain diaper structure during prolonged use and soft-fit waistbands designed to minimize skin irritation and breakdown. Multiple product variants offering extended absorption protection demonstrate the industry's growing emphasis on personalized continence care products tailored to distinct clinical needs and lifestyle requirements.

Advanced Diagnostics Modernizing Bladder Function Assessment

Diagnostic innovation is playing an increasingly important role in continence care management. Bright Uro received FDA 510(k) clearance for its Glean® Abdominal Sensor, expanding the functionality of the wireless and catheter-free Glean® Urodynamics System. The enhanced platform enables comprehensive multi-channel urodynamic studies, including measurement of abdominal and detrusor pressures, without relying on conventional transurethral and rectal catheter systems. This advancement significantly improves patient comfort during diagnostic evaluations while supporting more efficient assessment of lower urinary tract dysfunction and bladder disorders.

Catheter Technology and Minimally Invasive Therapies Advancing Clinical Outcomes

Technological advancements in catheter design and procedural devices are improving treatment pathways for continence patients. Clinical studies have highlighted the adoption of Micro-hole Zone Technology (MHZT) in intermittent urinary catheters, replacing traditional two-eyelet drainage designs. By incorporating up to 80 distributed micro-holes, the technology promotes continuous urinary flow, reduces mucosal suction, minimizes tissue trauma, and lowers the risk of incomplete bladder emptying and infection. Additionally, Carbon Medical Technologies, Inc. secured FDA 510(k) clearance for its InjecSURE® Injection System. The device is specifically engineered for the precise delivery of therapeutic bulking agents into urethral tissues during cystoscopic procedures, supporting minimally invasive treatment approaches for patients suffering from severe stress urinary incontinence. These innovations reflect the industry's ongoing commitment to improving both diagnostic and therapeutic continence care solutions.

Continence Care Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Continence Care market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Essity AB, Kimberly-Clark Corporation, Coloplast A/S, ConvaTec Group Plc, B. Braun SE, Paul Hartmann AG, Medline Industries, LP, Cardinal Health, Inc., Ontex Group NV, Unicharm Corporation. The Continence Care market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Continence Care industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Continence Care Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Continence Care companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Continence Care markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Continence Care Market Competitive Benchmarking and Company Analysis

Leading companies in Continence Care industry include- Essity AB, Kimberly-Clark Corporation, Coloplast A/S, ConvaTec Group Plc, B. Braun SE, Paul Hartmann AG, Medline Industries, LP, Cardinal Health, Inc., Ontex Group NV, Unicharm Corporation. The Continence Care market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Continence Care Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Continence Care market remains one of the strongest-performing segments in the country.
The US Continence Care Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Continence Care market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Continence Care industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Continence Care markets

Canada's strong Continence Care sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Continence Care market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Continence Care Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Continence Care market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Continence Care population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Continence Care industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Continence Care market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Continence Care sales through 2034

France Continence Care companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Continence Care Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Continence Care distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Continence Care Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Continence Care market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Continence Care industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Continence Care industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Continence Care Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Continence Care market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Continence Care market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Continence Care Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Continence Care Market Segmentation

By Product Type
Absorbent Products
Non-Absorbent Products
Skin Care Products
By Condition
Stress Incontinence
Urge Incontinence
Mixed Incontinence
Functional Incontinence
Fecal Incontinence
By Material
Plastic
Cotton Fabrics
Super Absorbent Polymers
Latex and Silicone
By Gender
Male
Female
By End User
Hospitals and Clinics
Home Care Settings
Ambulatory Surgical Centers
Nursing Homes and Long-term Care Facilities

Top Companies in Continence Care Industry

Essity AB
Kimberly-Clark Corporation
Coloplast A/S
ConvaTec Group Plc
B. Braun SE
Paul Hartmann AG
Medline Industries, LP
Cardinal Health, Inc.
Ontex Group NV
Unicharm Corporation

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025